ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR^® POC instrument.

On August 20th the German Minister of Health, Jens Spahn visited the Red Cross Hospital of Mölln-Ratzeburg.

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

Menarini Diagnostics announces Technology Transfer Agreement to develop its own COVID 19 RT PCR assay

Florence and Trieste, Italy, July 16th, 2020

Credo Diagnostics Biomedical And A. Menarini Diagnostics Sign An Exclusive Distribution Agreement For Sars-cov-2 Assay On The Vitapcrtm Platform

Florence, Italy and Singapore, April 2nd, 2020 – Credo Diagnostics Biomedical Pte. Ltd. and A. Menarini Diagnostics announced today they have entered into an exclusive

Our values

4 values, which have given life to Menarini and shaped its history

ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR® POC instrument.

A.Menarini Diagnostics Announces Agreement with Skyla Corporation in the area of Point of Care Testing

Hsinchu, Taiwan and Florence, Italy, July 24th, 2020

Menarini Diagnostics announces Technology Transfer Agreement to develop its own COVID 19 RT PCR assay

Credo Diagnostics Biomedical And A. Menarini Diagnostics Sign An Exclusive Distribution Agreement For Sars-cov-2 Assay On The Vitapcrtm Platform

Our values

ralesci Congresses with "Zero Impact®" on the environmentive drug for chronic hyperuricaemia in gout.D VitaPCR^® POC instrument.